Announcing the WSIS 2023 World Summit on the Information Society Forum: ICTs and Older Persons Track

May 8-12, 2023 / Geneva, Switzerland

The Global Coalition on Aging is excited to again be leading the special track on ICTs and Older Persons at the 2023 WSIS Forum in partnership with ITU.

Join us for this series of thought-provoking panels exploring how digital technology is transforming the future of aging and to learn more about how individuals and organizations can help lead this process by registering here.

The ICTs and Older Persons track will feature a new panel each day from May 8-12 at 8:00-9:00 AM EDT/14:00-15:00 CEST:

Monday, May 8 | How Tech is Defining Medical Innovation and Integrated Care

Michael Devoy, Executive Vice President for Medical Affairs and Pharmacovigilance, Bayer

Mario Barbagallo, President, International Association of Gerontology and Geriatrics, European Region (IAGG-ER)

Jian Yang, Vice President, Digital Health GMAO, Eli Lilly & Co

Eric Sutherland, Senior Health Economist, OECD

Alexandra Bhatti, Director, US Vaccine Public Policy, Merck

 

Tuesday, May 9 | Smart Homes Matter

Emily Allen, Director of Thought Leadership and Advocacy, Honor Home Instead

Kazumi Nishikawa, Director, Information Technology Division, Ministry of Economy, Trade and Industry, Japan

Keren Etkin, Gerontologist & Founder, TheGerontechnologist.co

Philip Hogan, Chief Executive and Founder, Origin Care

Nick Wilson, Business Integration Leader, Ambulatory Monitoring and Diagnostics, Philips

 

Wednesday, May 10 | The Age Tech Revolution – the Investment Opportunity

Abby Miller Levy, Managing Partner & Co-Founder, Primetime Partners

Kevin Crain, Head of Workplace Solutions Integration, Bank of America

Danielle Duplin, Founder, Executive Producer of Innovation Programs, AGENCY

Anthony Lambrou, Corporate Strategy and Digital Innovation Lead, Pfizer

 

Thursday, May 11 | Equity and Technology Across the Life Course – Readjusting Ageist Attitudes

Malik Afegbua, Visual Artist, Fashion Show for Elders

Meri Frischman, Founder, Pro-Age Woman

Charles Haddad, AVP, Global Digital Health, Eli Lilly & Company

Amal Abou Rafeh, Chief of Programming on Ageing Section, United Nations Office of Economics and Social Affairs

 

Friday, May 12 | Creating the New Urban Infrastructure that Supports Healthy Aging

Thiago Hérick de Sá, Senior Technical Officer, World Health Organization

Joseph Musgrave, CEO, Home and Community Care Ireland

Frans-Anton Vermast, Strategy Advisor & International Smart City Ambassador, Amsterdam

Brian Kennedy, Arts Consultant

Lois Privor-Dumm, Senior Advisor, Policy Advocacy & Communications and Director of Adult Immunization at the International Vaccine Access Center (IVAC), Johns Hopkins University

 
Register now! Upon completing the registration process, you will receive a confirmation email with a link to download calendar invites for each of your selected sessions. Sessions will also be streamed live from the WSIS Forum Facebook page.
Click here for the latest agenda announcements for the 2023 WSIS Forum. Please contact [email protected] with any questions.

 

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.